Cargando…

Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study

Background: Thalidomide has been reported as a promising treatment for reducing transfusion volume in adults with β-thalassemia. However, the evidence about the safety and efficacy of thalidomide on children with transfusion dependent β-thalassemia (TDT) is scarce. Methods: Seventy-seven children wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xinyu, Hu, Shuting, Liu, Yong, Huang, Junjiu, Hong, Weicong, Xu, Luhong, Xu, Honggui, Fang, Jianpei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397440/ https://www.ncbi.nlm.nih.gov/pubmed/34456732 http://dx.doi.org/10.3389/fphar.2021.722502

Ejemplares similares

Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Chen, Jiang-Ming, et al.
Publicado: (2021)

Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
por: Chen, Yaocheng, et al.
Publicado: (2020)

Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent ß-Thalassemia
por: Che, Jinlian, et al.
Publicado: (2022)

Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis
por: Lu, Yanfei, et al.
Publicado: (2022)

Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report
por: Javed, Rizwan, et al.
Publicado: (2020)

Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study
por: Ali, Zahid, et al.
Publicado: (2023)

S272: SAFETY AND EFFICACY OF RM-001 IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA: EARLY RESULTS FROM THE ONGOING OF AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Liu, Rongrong, et al.
Publicado: (2023)

Thalidomide for Patients with β-Thalassemia: A Multicenter Experience
por: Yang, Kun, et al.
Publicado: (2020)

Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022)

A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients
por: Bhattacharjee, Urmimala, et al.
Publicado: (2023)

Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study
por: Chun, Geok Ying, et al.
Publicado: (2023)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Correction of β-thalassemia mutant by base editor in human embryos
por: Liang, Puping, et al.
Publicado: (2017)

The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
por: Rattananon, Parin, et al.
Publicado: (2021)

β-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2010)

Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis
por: Hatamleh, Modather I, et al.
Publicado: (2023)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023)

HBB-deficient Macaca fascicularis monkey presents with human β-thalassemia
por: Huang, Yan, et al.
Publicado: (2019)

The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan
por: Chang, Hsiu-Hao, et al.
Publicado: (2015)

Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia
por: Phanrahan, Paramee, et al.
Publicado: (2019)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

Health state utilities associated with treatment for transfusion-dependent β-thalassemia
por: Matza, Louis S., et al.
Publicado: (2019)

Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia
por: Haghpanah, Sezaneh, et al.
Publicado: (2022)

Real-World Presentation and Prognostic Effect of Allogeneic Blood Transfusion during the Intensive Induction Phase in Pediatric Acute Lymphoblastic Leukemia
por: Qiu, Kunyin, et al.
Publicado: (2023)

Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)

Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
por: Sookaromdee, Pathum, et al.
Publicado: (2018)

Quality of life in transfusion-dependent thalassemia patients
por: Alzahrani, Rizqallah A., et al.
Publicado: (2017)

Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia
por: Majumder, Anirban, et al.
Publicado: (2020)

Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients
por: Hashemieh, Mozhgan, et al.
Publicado: (2017)

Thalidomide Prevented and Ameliorated Pathogenesis of Crohn’s Disease in Mice via Regulation of Inflammatory Response and Fibrosis
por: Chen, Hongjin, et al.
Publicado: (2019)

Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia
por: Caprari, Patrizia, et al.
Publicado: (2023)

Comprehensive patient care improves quality of life in transfusion dependent patients with β-thalassemia
por: Ali, Salah S., et al.
Publicado: (2015)

Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran
por: Yaghobi, Maryam, et al.
Publicado: (2017)

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2021)

Osteoporosis-osteopenia syndrome in children with transfusion dependent thalassemia
por: Ong, Zhi-Miin, et al.
Publicado: (2015)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
por: Sleiman, Joseph, et al.
Publicado: (2018)

Leukocyte telomere length in patients with transfusion-dependent thalassemia
por: Nanthatanti, Nithita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3n6t7i1f6fnan3lar1bo14f3e7